Qube Research & Technologies Ltd

Position in XBIT — XBiotech Inc.

CIK 1729829 LONDON, X0

Position in XBIT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$77,211

+$33,288 QoQ

Shares Held

33,570

+79.6% QoQ

Ownership

0.110%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 36 holders

Holding Since

Jun 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. XBIT ranks #145 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$77,211	33,570	+79.6%	Shares	Sole	2026-08-14
2026-03-31	$43,923	18,691	-9.3%	Shares	Sole	2026-05-15
2025-12-31	$49,260	20,611	-32.0%	Shares	Sole	2026-02-17
2025-09-30	$80,643	30,317	-5.9%	Shares	Sole	2025-11-14
2025-06-30	$95,687	32,218	+149.4%	Shares	Sole	2025-08-14
2024-06-30	$66,393	12,917	-80.9%	Shares	Sole	2024-08-14
2024-03-31	$550,092	67,662	+19.8%	Shares	Sole	2024-05-14
2023-12-31	$225,908	56,477	+2106.1%	Shares	Sole	2024-02-13
2023-09-30	$10,547	2,560	-79.7%	Shares	Sole	2023-11-13
2022-09-30	$45,579	12,591	-12.5%	Shares	Sole	2022-11-14
2022-06-30	$81,010	14,389	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.